Is this you? Create Your Porfile
Avatar

Pasit Phiasivongsa

University of Illinois at Chicago

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Pasit Phiasivongsa is active.

Explore More

Publication

Featured researches published by Pasit Phiasivongsa.

Cancer Research | 2009

A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation

Jharna Datta; Kalpana Ghoshal; William A. Denny; Swarna A. Gamage; Darby G. Brooke; Pasit Phiasivongsa; Sanjeev Redkar; Samson T. Jacob

Cancer Research | 2007

Delivery of 5-Aza-2′-Deoxycytidine to Cells Using Oligodeoxynucleotides

Christine B. Yoo; Shinwu Jeong; Gerda Egger; Gangning Liang; Pasit Phiasivongsa; Chunlin Tang; Sanjeev Redkar; Peter A. Jones

Archive | 2007

Quinoline derivatives for modulating dna methylation

Pasit Phiasivongsa; Sanjeev Redkar; Swarna A. Gamage; Darby G. Brooke; William A. Denny; David J. Bearss; Hariprasad Vankayalapati; Yong Xu; Krzysztof Swierczek

Archive | 2005

Salts of 5-azacytidine

Sanjeev Redkar; Pasit Phiasivongsa

American Journal of Hematology | 2007

Oral decitabine reactivates expression of the methylated γ-globin gene in Papio anubis

Donald Lavelle; Janet Chin; Kestis Vaitkus; Sanjeev Redkar; Pasit Phiasivongsa; Chunlin Tang; Roselle Will; Maria Hankewych; Bryan P. Roxas; Mahipal Singh; Yogen Saunthararajah; Joseph DeSimone

Archive | 2006

Azacytosine analogs and derivatives

Pasit Phiasivongsa; Sanjeev Redkar

Archive | 2005

Oral administration of decitabine salt

Sanjeev Redkar; Pasit Phiasivongsa

Archive | 2005

Salts of decitabine

Sanjeev Redkar; Pasit Phiasivongsa

Archive | 2010

PHARMACEUTICAL FORMULATIONS COMPRISING SALTS OF A PROTEIN KINASE INHIBITOR AND METHODS OF USING SAME

David J. Bearss; Rajashree Joshi-Hangal; Xiao-Hui Liu; Pasit Phiasivongsa; Sanjeev Redkar; Hariprasad Vankayalapati

Blood | 2009

Dose Intensive Administration of PR-047, a Novel Orally Bioavailable Inhibitor of the 20S Proteasome, Is Well Tolerated in Experimental Animals.

Tony Muchamuel; Shirin Kapur; Christopher J. Kirk; Jing Jiang; Susan Lee; Mark K. Bennett; Evan R. Lewis; Jinfu Yang; Mouhannad Jumaa; Eileen Ring; Pasit Phiasivongsa; Han-Jie Zhou; Zhengping Wang

Explore More

Collaboration

Dive into the Pasit Phiasivongsa's collaboration.

Top Co-Authors
Avatar

Sanjeev Redkar

Astex

View shared research outputs
Top Co-Authors
Avatar

Chunlin Tang

University of Illinois at Chicago

View shared research outputs
Top Co-Authors
Avatar

Donald Lavelle

University of Illinois at Chicago

View shared research outputs
Top Co-Authors
Avatar

Janet Chin

University of Illinois at Chicago

View shared research outputs
Top Co-Authors
Avatar

Kestis Vaitkus

University of Illinois at Chicago

View shared research outputs
Top Co-Authors
Avatar

Maria Hankewych

University of Illinois at Chicago

View shared research outputs
Top Co-Authors
Avatar

David J. Bearss

University of Arizona

View shared research outputs
Top Co-Authors
Avatar

Hariprasad Vankayalapati

University of Arizona

View shared research outputs
Top Co-Authors
Avatar

Joseph DeSimone

University of Illinois at Chicago

View shared research outputs
Top Co-Authors
Avatar

Mahipal Singh

Fort Valley State University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge